News
The top financial leader at Thermo Fisher Scientific Inc. plans to retire from the company in 2026 after more than a decade ...
16h
Zacks Investment Research on MSNHas BioNTech (BNTX) Outpaced Other Medical Stocks This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. BioNTech SE Sponsored ADR (BNTX) is a stock that can certainly grab the attention of ...
15hon MSNOpinion
Forget trade wars — the future isn’t about physical goods, but data, ideas and services
The chief engine of the U.S. economy lies in intangible investments, such as research and development, software, ...
20h
Best Life on MSNCOVID-Like Vaccine Could Help Cure “Every Single Cancer Patient,” Scientists Announce
By pairing an mRNA-style vaccine with traditional cancer immunotherapy drugs known as immune checkpoint inhibitors, they were ...
Scientists have discovered that Pfizer's COVID-19 vaccine may increase the risk of eye damage, leading to vision loss.The new study specifically examined how ...
15h
Zacks Investment Research on MSNBristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?
Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...
MIG Capital, through its MIG Fonds, is investing 3 million Swiss Francs (CHF) in the Swiss start-up which designs precision drugs against eukaryotic pathogens.Digitalis Ventures co-leads the round ...
Founded in 1998, Genmab develops customised antibodies for use in cancer treatments. Historically, the group has licensed its technology and the commercialisation of its drugs to large pharma giants ...
Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results